Large-Joint Reconstructive Implants | Market Insights | US | 2022
The COVID-19 pandemic has significantly impacted the US large-joint reconstructive implant market, as regional restrictions on elective procedures resulted in delays to hip and knee replacement procedures and declining unit sales. Resurging cases at the end of 2020 resulting in new restrictions have impacted procedures into 2021. Recovery of the market will depend on a number of factors, including the ability of facilities to return to pre-pandemic capacity and the pace of vaccine distribution in the US. Although the crisis has significantly impacted the market in the short-term, other factors will continue to drive market growth in the long-term. Demand for better patient outcomes will drive the uptake of novel technologies such as patient-conforming and 3-D printed implants, robotic- and navigation-assisted surgeries, and minimally invasive techniques, supporting the expansion of the US large-joint reconstructive implant market. However, downward pricing pressures driven by bundled payment initiatives such as the CJR and BPCI Advanced models, growing outpatient joint replacement volumes, and the increasing influence of GPOs will limit overall revenue potential to some degree.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for large-joint reconstructive implants in the US across a 10-year period.
